Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,108 | -20,063 | -16,004 | -10,823 | -5,062 |
| Depreciation Amortization | 426 | 1,651 | 1,228 | 801 | 394 |
| Accounts payable and accrued liabilities | 232 | -1,328 | -924 | -733 | -752 |
| Other Working Capital | -617 | -4,743 | -3,215 | -3,102 | -3,035 |
| Other Operating Activity | -49 | 3,190 | 2,666 | 1,846 | 1,324 |
| Operating Cash Flow | $-4,116 | $-21,293 | $-16,249 | $-12,011 | $-7,131 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -120 | -91 | -64 | -7 |
| Purchase Of Investment | N/A | -50 | N/A | N/A | N/A |
| Investing Cash Flow | $-5 | $-170 | $-91 | $-64 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -44 | -2,090 | -2,263 | -1,659 | -1,267 |
| Common Stock Issued | 5,374 | 20,795 | 20,307 | 10,079 | 10,076 |
| Other Financing Activity | -171 | -1,246 | -925 | -781 | -701 |
| Financing Cash Flow | $5,159 | $17,459 | $17,119 | $7,639 | $8,108 |
| Exchange Rate Effect | -7 | 14 | 6 | 6 | N/A |
| Beginning Cash Position | 5,819 | 9,809 | 9,809 | 9,809 | 9,809 |
| End Cash Position | 6,850 | 5,819 | 10,594 | 5,379 | 10,779 |
| Net Cash Flow | $1,031 | $-3,990 | $785 | $-4,430 | $970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,116 | -21,293 | -16,249 | -12,011 | -7,131 |
| Capital Expenditure | -5 | -120 | -91 | -64 | -7 |
| Free Cash Flow | -4,121 | -21,413 | -16,340 | -12,075 | -7,138 |